The translocation t(11;19) is frequently found in acute leukemia in infants. This event truncates the protooncogene MLL and fuses the 5' end of MLL in frame with the ENL gene. ENL contributes a crucial protein ± protein interaction domain to the resulting oncoprotein MLL ± ENL. Here we show by yeast two-hybrid assays, GST-pull-down experiments and in a far western blot analysis that this domain is necessary and sucient to recruit a novel member of the human Polycomb protein family (hPc3). hPc3 RNA was detected throughout the human hematopoietic system. Similar to other Polycomb proteins hPc3 acts as a transcriptional repressor. The ENL-hPc3 interaction was veri®ed by mutual coprecipitation of the proteins from cell extracts. ENL and hPc3 tagged with¯uorescent proteins co-localized in living cells in a nuclear dot pattern. An internal region of hPc3 was responsible for binding to ENL. Finally, hPc3 binds to the C-terminus of AF9, another common MLL fusion partner. The recruitment of a repressive function by ENL opens up a new insight into a possible mechanism of leukemogenesis by the fusion protein MLL ± ENL. Oncogene (2001) 20, 411 ± 419.
Introduction
ENL is a member of a heterogeneous group of at least 22 proteins that have been originally identi®ed as fusion partners of the mixed lineage leukemia (MLL) protein (Rubnitz et al., 1994; Tkachuk et al., 1992) . The presence of MLL fusion proteins is a common characteristic of a class of very aggressive acute leukemias that occur in infants. These MLL fusion proteins are created by chromosomal aberrations, predominantly by reciprocal translocations. In these cases the terminal portion of the MLL gene is deleted and replaced in the correct reading frame by the respective MLL fusion partner. The transcription and translation of this genetic chimera leads to the production of a protein with a novel combination of functional entities (Dimartino and Cleary, 1999; Look, 1997) .
The universal target of these aberrations, the MLL gene (also known as HRX, ALL-1 and Htrx) at 11q23, is a human homolog of Drosophila trithorax (trx) (Djabali et al., 1992; Gu et al., 1992; Tkachuk et al., 1992; Ziemin-van der Poel et al., 1991) . TRX is an epigenetic regulator that is required to maintain, but not to initiate, a spatial and temporal transcription pattern of the respective target genes. The homeobox containing genes of the Hox-cluster (Hom-C) are con®rmed targets of TRX (van Lohuizen, 1999) . Knockout studies have shown that MLL has a similar function in mammals (Yu et al., 1998 (Yu et al., , 1995 . MLL and TRX are the prototypes of a genetically de®ned group of proteins, the trithorax group (trxG) that is involved in transcriptional activation through changes of the chromatin architecture. The function of the trxG of proteins is counteracted by the Polycomb group (PcG) of proteins; for a review see (van Lohuizen, 1999) . PcG proteins act to establish a repressive chromatin state and are exempli®ed by the Drosophila Polycomb protein. Together the PcG and trxG protein complexes maintain a stable and heritable transcriptional state of the genome and hence constitute the`transcriptional memory' of a cell.
For MLL two lines of evidence support the assumption that the generation of MLL fusion proteins creates active oncogenes that are responsible for the transformation of hematopoietic cells: (i) Retrovirally transduced MLL ± ENL, the product of a translocation t(11;19), transforms murine bone marrow cells in colony forming assays and upon reintroduction into mice these cells cause myeloid leukemias (Lavau et al., 1997) ; (ii) Mice carrying a`knock-in' allele of a t(9;11) translocation that fuses MLL with AF9 also develop leukemias (Corral et al., 1996; Dobson et al., 1999) .
The molecular analysis of the fusion proteins revealed that MLL contributes two DNA binding motifs, the AT-hooks and the CXXC or methyltransferase domain (Dimartino and Cleary, 1999; Slany et al., 1998) , but the role of the proteins joined to MLL remains enigmatic. There is no apparent unifying feature amongst the 22 fusion partners cloned up to date and it has been suggested that the nature of the partner protein is of minor importance as long as it supplies a general function e.g. protein stabilization or dimerization capabilities. A speci®c function of the fusion partner, however, must be required because in the knock-in studies neither the N-terminal portion of MLL alone, nor a MLL protein fused to a portion of the Myc protein (Myc-tag) showed transforming activities (Corral et al., 1996) .
For the MLL ± ENL protein the contribution of the fusion partner ENL was examined in detail by a structure-function analysis (Slany et al., 1998) . The oncogenic capability of MLL ± ENL was essentially dependent on the integrity of a small C-terminal hydrophobic domain (CTD) in ENL. This CTD was both necessary and sucient for MLL ± ENL function. The fusion of the C-terminal 126 amino acids of ENL with MLL created a protein with equal transforming potential as full-length MLL ± ENL. The hydrophobic nature of this domain and the predicted threedimensional folding of two amphipatic helices made it likely that this portion of ENL constitutes a proteinprotein interaction domain. In a previous study we therefore identi®ed proteins interacting with the Cterminal portions of ENL (Garcia-Cuellar et al., 2000) . In an extension of these studies a screen was now conducted searching for proteins that speci®cally bind to the CTD of ENL. Here we report that a recently described (Hemenway et al., 2000) human ortholog of the Drosophila Polycomb protein, human Polycomb 3 (hPc3), interacts with ENL through its CTD. This domain was necessary and sucient for the ENL-hPc3 interaction in a yeast two-hybrid system, GST-pulldowns and far-Western blots. The two proteins coimmunoprecipitated and co-localized in living cells. hPc3 was expressed in the hematopoietic system and similar to Polycomb conferred a repressive function on transcription. Finally hPc3 also interacted with AF9 supporting a more general possible function of this molecular association for the etiology of leukemias generated by MLL fusion proteins.
Results

Identification of a protein that specifically interacts with the CTD of ENL
To identify proteins that interact speci®cally with the CTD of ENL, all clones obtained in a previous twohybrid experiment (Garcia-Cuellar et al., 2000) , in which a more extended C-terminal portion of ENL was used as bait (amino acids 231 ± 559), were rescreened with a bait containing exclusively the CTD of ENL (amino acids 431 ± 559). The N-terminal half of ENL (amino acids 1 ± 281) and a mutant verison of the original bait (amino acids 231 ± 544) lacking the last 15 amino acids of the CTD served as controls. When fused to MLL this CTDD15 mutation completely abrogated the oncogenic function of the resulting chimeric protein. The integrity of the bait proteins was veri®ed by immunoblotting of extracts from the transformed yeast cells (Figure 1a) . None of the baits showed endogenous transactivation capability of the histidine or adenine reporter genes (not shown). Three out of 18 originally positive clones interacted speci®-cally with the CTD (bait ENL 431 ± 559) but not with the N-terminal portion of ENL (ENL 1 ± 281) or a CTDD15 mutant (ENL 231 ± 544) ( Figure 1b ). All three clones contained identical inserts.
To verify this interaction in vitro a far-Western blot analysis was conducted. For this purpose the ENL portions that had served as baits in the two-hybrid experiments were fused to glutathione-S-transferase and the corresponding fusion proteins were expressed in yeast and puri®ed. The recombinant GST ± ENL proteins were separated by SDS polyacrylamide gelelectrophoresis, blotted onto nitrocellulose and subsequently renatured to their native conformation. Labeled CTD-interacting protein was prepared by in vitro transcription/translation of the insert from the two-hybrid clone (excluding the GAL4 portion) in the presence of [ 35 S]methionine. The resulting radioactive protein was used to probe the ®lter carrying the immobilized GST ± ENL proteins. The membrane was washed to eliminate unspeci®c interactions and bound radioactivity was revealed by autoradiography. The labeled CTD interacting protein was retained exclusively by a GST ± ENL 231 ± 559 fusion but not by GST alone or GST fused to the N-terminal amino acids 1 ± 281 of ENL. A deletion of the last 15 amino acids from the ENL CTD completely abolished the association with the CTD-binding protein in this assay ( Figure 1c , left panel). As a control for equal loading and immobilization of the respective GST fusion proteins the same membrane was reprobed in a conventional immunoblot with an anti-GST antibody ( Figure 1c , right panel).
To exclude unspeci®c associations due to the high local concentrations of immobilized interaction target on the membranes additional GST-pull-down tests were performed. In these experiments 35 S marked CTD-interacting protein was incubated in solution with the corresponding recombinant GST ± ENL proteins. The resulting protein complexes were adsorbed through the glutathione binding activity of the GST moiety by glutathione agarose. Unspeci®cally associated proteins were washed away and the proteins remaining bound to the beads were analysed by SDS polyacrylamide gelelectrophoresis followed by autoradiography. The results con®rmed that the CTDbinding protein interacts eciently with the GST ± ENL231 ± 559 construct but not with GST ± ENL1 ± 281 fusion protein. In the pull-down experiments a weak anity of the CTD-binding protein was detectable also for the GST ± ENLD15 protein. However, binding to this mutant protein was more than 10 times weaker than the interaction with the native Cterminus of ENL. As a control 25% of the originally labeled CTD binding protein was applied to the same gel next to the pull-down products (Figure 1d ).
The CTD-binding protein is identical with human Polycomb 3 and functions as a transcriptional repressor Sequencing of the 1.35 kb insert of the two-hybrid clones revealed a continuous reading frame of 1050 bp followed by a 258 bp untranslated 3' sequence and the remnants of a polyA tail presumably reverse transcribed during the production of the oligodT-primed cDNA library. Blast analysis (Altschul et al., 1990) and database comparisons of the translated amino acid sequence resulted in multiple matches with a signi®cant homology to several Polycomb proteins from dierent species.
A partial N-terminal chromodomain and a COOHbox were present in the ENL CTD-interacting protein.
These two features characterize all members of the Polycomb (Pc) protein family and are conserved from Drosophila to human Pc proteins. The highest degree of homology of the complete CTD-interacting protein (86% identical) was noted to a recently described murine Polycomb protein termed mouse Polycomb 3 (mPc3) (Hemenway et al., 2000) (accession #AAF26713). A stretch of amino acids with alternating charge (RD domain) and an amino acid triplet (SST) S-labeled hPc3 protein in binding buer and protein complexes were precipitated with glutathione-agarose beads. After washing bound proteins were separated by SDS polyacrylamide gelelectrophoresis. Radioactive material was detected in the dried gel by autoradiography. As a control 25% of the original labeled input hPc3 was run alongside the precipitated samples. Lane 1: Input, lane 2: GST-ENL1 ± 281, lane 3: GST-ENL231 ± 559, lane 4: GST-ENL231 ± 544. The relative positions of molecular weight markers are indicated were absent in the reported sequence of mPc3. Outside these regions mPc3 diered from hPc3 only by 22 mostly conservative amino acid changes (Figure 2a ). Therefore we concluded that the ENL CTD-binding protein is the human counterpart of mPc3 and accordingly termed it human Polycomb 3 (hPc3). The comparison also revealed that the original two-hybrid candidate represented only a partial clone lacking the N-terminal 39 amino acids of the chromodomain of hPc3. To complete these missing sequences a search in the EST database was conducted. The query detected a cDNA of the IMAGE consortium that was isolated from a lung small cell carcinoma and that was identical over a 355 nucleotide stretch with the hPc3 cDNA isolated here (accession #AW250133, IMAGE #2821280). This EST clone extended further into the 5' direction and encoded the missing 39 amino acids of the hPc3 chromodomain (Figure 2a ). For all subsequent experiments a full-length version of hPc3 was generated by PCR ( Figure 2a ). After completion of this work two other database entries with a signi®cant match to hPc3 and mPc3 became available (accession #AF266479, AF174482). The ®rst clone was termed rectachromel (RC1) and was isolated in a screen for cDNAs overexpressed in colorectal carcinoma (unpublished, annotations to accession #AF266479). RC1 is identical to hPc3 except for a small region where a frameshift in the cDNA creates a stretch of 17 amino acids without any Polycomb homology and an additional three amino acid changes in the very Nterminus (Figure 2a) . The second protein, also labeled hPc3, was found in a two-hybrid screen for RING protein binding partners (Bardos et al., 2000) . This protein is identical to the hPc3 described here except for the ®rst 10 amino acids that correspond to the mPc3 sequence.
In mice Pc3 expression was detected by Northern blotting only in embryonic but not in adult tissues (Hemenway et al., 2000) . Correspondingly, we were unable to detect hPc3 expression by Northern blot Figure 2 Characterization of the ENL binding partner hPc3. (a) Amino acid comparison between human (hPc3), mouse Polycomb3 (mPc3) and human rectachrome 1 (RC1). A line symbolizes identical amino acids; substitutions are given in the one letter code. In the hPc3 sequence the parts derived from the original two-hybrid clone and from EST data are indicated by arrows. Boxes indicate conserved domains. (b) Expression of hPc3 in dierent human hematopoietic tissues as detected by RT ± PCR on a commercial multiple tissue cDNA panel. First strand cDNA was generated from polyadenylated RNA isolated from various hematopoietic compartments and normalized with respect to the expression of four dierent housekeeping genes. Equal amounts of cDNA served as a template for the ampli®cation of a non-conserved 500 bp region of hPc3 corresponding to amino acids 123 ± 290. The ®gure shows 1/3 of a 50 ml PCR reaction after 33 ampli®cation cycles. TO=tonsil, SP=spleen, PL=peripheral blood leukocyte, LN=lymph node, FL=fetal liver, TY=thymus, BM=bone marrow, +=positive control with hPc3 cDNA as template, 7=negative control with ddH 2 O as template. (c) hPc3 acts as a transcriptional repressor in transient reporter gene assays. A plasmid containing a luciferase gene driven by a SV40 promoter/enhancer combination with three concatemerized GAL4 recognition sites served as a reporter construct (lower panel). 0.1 mg of reporter was cotransfected into 293 cells together with the indicated amounts of an expression vector coding for a fusion of the GAL4 DNA binding domain with full-length hPc3 (GAL4-hPc3). The basal activity of the reporter in the absence of GAL4-hPc3 was set to 100%. The mean and standard deviations of triplicate experiments are shown (left panel). The expression of the GAL4-hPc3 construct was veri®ed by western analysis of the transfected cell lysates (right panel), cont=control, untransfected 293 cells analysis in hematopoietic cell lines (not shown). To probe for the expression of hPc3 in the hematopoietic compartment with a more sensitive method a PCR experiment was conducted. A commercial multiple tissue cDNA panel with cDNAs derived from polyadenylated RNAs of dierent human hematopoietic tissues was used as a template. These cDNAs are prenormalized to four dierent housekeeping genes (atubulin, b-actin, G3PDH, phospholipase A2) and allow a semi-quantitative approximation of the expression level of the ampli®ed gene in the individual tissues. For the PCR reactions a 500 bp region of the nonconserved internal portion of hPc3 was ampli®ed (corresponding to amino acids 123 ± 290). An ampli®-cation product was seen in all tissues tested (tonsil, spleen, peripheral blood leukocytes, lymph node, fetal liver, thymus, bone marrow) but not in the negative control omitting the template (Figure 2b ). Detectably higher amounts of hPc3 RNA were present in spleen, lymph node, thymus and in fetal liver.
Reporter gene assays were performed to test for a transcriptional repressor function of hPc3. Although Polycomb proteins act on chromatin their repressive function can also be detected in transcription assays with transiently transfected reporter gene plasmids (Bunker and Kingston, 1994) . In these tests the respective Pc proteins have been recruited to the DNA by a GAL4 DNA binding domain. A similar fusion of the GAL4 DNA binding domain and fulllength hPc3 was constructed and tested with a reporter plasmid that contained three copies of the GAL4 DNA recognition sequence positioned immediately upstream of an SV40 promoter/enhancer combination ( Figure 2c, lower panel) . Increasing amounts of GAL4-hPc3 expression plasmid were cotransfected into 293 cells together with a constant quantity of luciferase reporter plasmid. The GAL4-hPc3 protein reduced the promoter activity to about 30% of the basic level (Figure 2c, upper panel, left) . The correct expression of the GAL4-hPc3 fusion was veri®ed by immunoblotting of 293 cell extracts with an anti-GAL4 DNA binding domain antibody (Figure 2c , upper panel, right). The cotransfection of full-length hPc3 without the GAL4 moiety did not aect the promoter activity thus excluding a general transcriptional eect (not shown).
hPc3 co-precipitates with ENL and both proteins co-localize in living cells
To con®rm the ENL-hPc3 interaction in living cells, co-immunoprecipitation experiments with epitope tagged versions of hPc3 and ENL were performed. To this end full length ENL, full-length ENL with the D15 mutation and the complete hPc3 molecule were tagged at their N-termini either with a`¯ag' tag (¯ag-ENL,¯ag-ENLD15) or a with a haemagglutinin epitope (HA-hPc3) respectively. Flag-tagged proteins were immunoprecipitated with an anti-¯ag antibody from extracts prepared from 293 cells that were transiently transfected with the expression plasmids.
The precipitates were analysed by SDS gelelectrophoresis followed by immunoblotting with an anti-HA antibody. HA-hPc3 was co-precipitated exclusively from cell extracts containing¯ag-ENL but not from lysates of cells expressing¯ag-ENLD15. An unspeci®c association of HA-hPc3 with the immunological reagents was excluded, because no HA reactive protein was precipitated in a control reaction from cells that had not been transfected with¯ag-ENL or¯ag-ENLD15 (Figure 3, left panel) . The expression of HA-hPc3,¯ag-ENL and¯ag-ENLD15 in the transfected cells was con®rmed by Western blotting of cell extracts without previous immunoprecipitation. In a reciprocal experiment HA-hPc3 co-precipitated¯ag-ENL but not¯ag-ENLD15 or any other¯ag-reactive protein (Figure 3,  right panel) .
The intracellular localization of ENL and hPc3 was determined in un®xed, living cells. For this purpose the full-length coding region of ENL was fused to the gene for enhanced green¯uorescent protein (GFP ± ENL). Similarly a fusion of hPc3 and red¯uorescent protein was constructed (hPc3-Red) and both constructs were cotransfected into 293 cells. When examined in ā uorescence microscope both proteins localized in a nuclear granulate or punctuated pattern with some cells showing additional brighter and larger nuclear dots (Figure 4a,b) . GFP ± ENL and hPc3-Red colocalized in all of the nuclear dots. An overlay of the images taken in the red and green spectral areas revealed a perfect co-localization of these proteins also in the smaller nuclear granules (Figure 4c ± e) .
Identification of the ENL binding domain in hPc3 and detection of a hPc3-AF9 interaction
In a structure-function analysis the minimally sucient ENL binding domain of hPc3 was identi®ed. Fulllength hPc3 and a series of hPc3 deletion mutants were used as interaction targets in a two-hybrid system with full-length ENL as bait. The mutants were constructed in the two-hybrid vector pACT2 and the expression in yeast was veri®ed by immunoblot with an antibody detecting the GAL4 transactivation domain in the fusion protein (Figure 5a, right panel) . When tested in the reporter strain PJ69-4A all hPc3 mutants containing the amino acids 250 ± 349 upstream of the conserved COOH-box scored positive (Figure 5a ). No special motif or conserved sequence was detected in this region (not shown).
The CTD of ENL shares considerable homology with the C-terminus of another frequent MLL fusion partner, AF9 (Iida et al., 1993) . To test for a possible interaction between the C-terminus of AF9 and hPc3, the C-terminal 95 amino acids of AF9 were used as bait in a two-hybrid experiment. The AF9-hPc3 combination produced a positive readout in the yeast reporter strain and facilitated vigorous growth on histidine-and adenine-selective medium similar to the positive control (Figure 5b, left panel) . The identical domain in hPc3 was responsible for the binding to both ENL and AF9 (not shown).
Discussion
The C-terminal domain of the ENL moiety in the MLL ± ENL oncoprotein associated with childhood leukemia is essential for the transforming capacity of this fusion protein (Slany et al., 1998) . Here we show that this CTD is necessary and sucient for the interaction of ENL with the novel human Polycomb family-member Polycomb3. The CTD of ENL binds to hPc3 in two-hybrid assays, far-Western blots and GSTpull-down experiments. In addition, the two proteins were mutually co-precipitated from cell extracts and uorescent versions of ENL and hPc3 co-localized in the nuclei of living cells in a distinct characteristic pattern.
The distribution of GFP ± ENL and hPc3-Red in nuclear granules and some larger interspersed dots corresponded exactly to the staining pattern observed for endogenous hPc3 in a recently published immunohistochemical analysis (Bardos et al., 2000) . In this study Bardos et al. (2000) identi®ed hPc3 as an interaction partner of the RING1 protein. Furthermore they described an association of the two proteins with the Polycomb related protein Bmi-1 in nuclear`PcG' bodies of a human osteosarcoma cell line. It is known that Polycomb and Polycomb-group proteins are members of high molecular-weight multi-protein complexes; reviewed in (Cairns, 1998; Kadonaga, 1998; Struhl, 1998) . These complexes correspond to the visible nuclear dots and appear to assemble on the cognate response elements to induce a`repressive' chromatin structure presumably by the recruitment of histone deacetylases. Despite the chromatin-mediated nature of the repressor function their function can be detected in transient reporter assays and this holds true also for hPc3 (Bunker and Kingston, 1994) .
The association and colocalization of ENL with hPc3 makes it very likely that ENL is also a component of the PcG complex. In addition to the CTD, ENL also contains a pronounced hydrophobic N-terminus. It is easy to envisage that the assembly of a huge protein complex requires bridging and adaptor proteins and we surmise that ENL might serve such a function.
The recruitment of a repressor complex by the CTD of ENL (and AF9) also opens up interesting implications for the function of the MLL ± ENL and MLL- Figure 3 Co-immunoprecipitation of ENL and hPc3. Expression constructs for a full length¯ag-tagged ENL (¯ag-ENL), a fulllength¯ag-tagged ENL with a 15 amino acid deletion at the end of the CTD (¯ag-ENLD15) and a full-length HA tagged hPc3 were transfected into 293 cells as indicated. Cell extracts were prepared and precipitated with a mouse monoclonal anti-¯ag antibody followed by immunoblot analysis with a rat monoclonal anti-HA antibody (left panel). In a reciprocal experiment aliquots of the same extract were precipitated with a rabbit polyclonal anti-HA antiserum followed by immunoblot with the¯ag monoclonal (right panel). Due to some unspeci®c cross-reaction of secondary reagents the immunglobulin chains are visible after precipitation with the polyclonal antibody (right panel). The expression of each epitope tagged construct was veri®ed by direct Western blotting without previous immunoprecipitation. The positions of molecular weight marker proteins are shown AF9 oncoproteins in leukemogenesis. Normal MLL is involved in the transcriptional activation of genes through changes of chromatin structure. At least some of the MLL targets must be genes essential for hematopoietic development because fetal liver hematopoiesis in MLL 7/7 knockout mice and the hematopoietic capabilities of MLL 7/7 ES cells were severely impaired (Fidanza et al., 1996; Hess et al., 1997; Yagi et al., 1998) . It is therefore tempting to speculate that the MLL ± ENL oncoprotein might work by a dominant negative mechanism. MLL and MLL-fusion proteins generally co-localize (Yano et al., 1997) and the DNA binding activities of MLL are conserved in all known MLL fusions. The ENL moiety in MLL ± ENL would bring the PcG complex to the sites of MLL target genes, inhibit their transcription and as a result block further hematopoietic dierentiation.
Two examples are known for the acquisition of a dominant negative function by a chimeric fusion protein through the recruitment of repressor complexes. The most frequently found translocation in acute myeloid leukemia, t(8;21) juxtaposes the AML1 gene from chromosome 21, which encodes a transcription factor, with the ETO gene on chromosome 8 (Downing, 1999; Friedman, 1999) . Similar to MLL, AML1 is essential for the transcription of a number of hematopoietic-speci®c genes. Targeted disruption has demonstrated that AML1 and its heterodimerization partner CBFb are essential for de®nitive hematopoiesis of all lineages in mouse fetal liver. The fusion partner ETO in the leukemogenic translocation 8;21 was found to interact with the nuclear receptor corepressor/ mSin3/histonedeacetylase complex (NcoR-C), which mediates transcriptional repression by deacetylating histones and creating repressive chromatin structures (Wang et al., 1998) . An analogous case is encountered in the retinoic acid resistant cases of promyelocytic leukemias that carry a fusion of the PLZF gene with the gene coding for the retinoic receptor a. PLZF also interacts with the NcoR-C and confers a repressive function to the nuclear hormone receptor RARa that cannot be abrogated by the cognate inductive eector retinoic acid (RA). RA is an important activator of genes essential for hematopoietic development that remain silent in cells containing the PLZF-RARa fusion (David et al., 1998; Slack and Gallagher, 1999) .
The binding of a repressor by the ENL CTD might seem surprising, because this domain has been found to contain an intrinsic transactivator activity either when tethered arti®cially to DNA by a GAL4-DNA binding domain or in connection with MLL (Rubnitz et al., 1994; Schreiner et al., 1999) . However, transactivation by ENL was observed only in certain cell types and it was restricted to speci®c promoter templates. The cell lines used for the reporter assays are not equivalent to the target cell that is transformed by the MLL ± ENL fusion protein and it is not known if hPc3 is present in these cells. In addition ENL overexpressed in the transient assays may outcompete the endogenous hPc3 and therefore cause artefactual eects. Alternatively, ENL may have more than one mode of action depending on the speci®c DNA/promoter environment. Proteins that can activate as well as repress transcription are well known, for example the transcription factor YY1 (Thomas and Seto, 1999) and the nuclear proto-oncoprotein Myc (Claassen and Hann, 1999) .
Finally, the MLL ± ENL fusion protein may also lead to a disruption of the architecture and function of the normal Polycomb protein complexes in the cell. This is important, because alterations in the expression level of Polycomb proteins have been linked to cell cycle control and tumorigenesis. An overexpression of a dominant negative version of hPc2 with a deletion of the COOH-box resulted in cellular transformation of ®broblasts (Satijn et al., 1997) . In the transformed cells c-myc expression was upregulated. Wild-type hPc2, in contrast, repressed the transcription of this protooncogene. Also the Polycomb-group protein Bmi-1 is connected to Myc and cell cycle control. The INK4A locus that codes for the negative cell cycle regulators p16 and p19 ARF is a direct target of Bmi-1 and overexpression of Bmi-1 cooperates with c-Myc by repressing these tumor suppressor proteins (Jacobs et al., 1999a,b) . Further experiments with authentic target cells of the transformation mediated by MLL ± ENL have to clarify which of the mechanisms outlined above contributes to this process.
Materials and methods
Plasmid and mutant construction
Plasmid constructs containing ENL sequences have been described previously (Garcia-Cuellar et al., 2000) . The respective plasmids are labeled`ENL' followed by numbers denoting the amino acid residues fused to the GAL4 DNA binding domain. To generate the GST ± ENL fusion proteins identical ENL portions were inserted into the correct frame of the pYEX 4T-3 yeast expression vector (Clontech) and labeled accordingly. The ENLD15 construct is a full length ENL sequence with a deletion of the last 15 C-terminal amino acids. Deletion versions of the two-hybrid hPc3 interaction target were cloned by inserting mutant hPc3 sequences into the vector pACT2 (Clontech). The series of deletion mutants contained the following amino acids of hPc3: hPc3 (full length hPc3) aa 1 ± 389, hPc3par (original two-hybrid candidate) aa 39 ± 389, D3 aa 39 ± 249, D4 aa 39 ± 349, D5 aa 250 ± 389, D7 aa 347 ± 389, D8 aa 250 ± 345, D8.2 250 ± 349. Epitope tagged versions of full length ENL and hPc3 were constructed by adding a N-terminal¯ag-tag or a N-terminal haemagglutinin tag to the coding sequences of full length ENL, ENLD15 and full length hPc3, respectively. Thē ag-ENL,¯ag-ENLD15 and HA-hPc3 proteins were expressed under the control of the CMV promoter in the eukaryotic expression vector pcDNA3.0 (Invitrogen, Groningen, The Netherlands). For the generation of a GFP ± ENL fusion the complete ENL cDNA was inserted in frame into the vector pEGFP-C1 (Clontech). In a similar way hPc3 was fused at its C-terminus with red¯uorescent protein in the vector pDsRedN1 (Clontech). AF9 sequences were ampli®ed by PCR from the AF-9 cDNA contained in the IMAGE consortium clone #194454 (GenBank accession #R83091). The C-terminal part of AF9 that shows the highest homology to ENL (amino acids 473 ± 568) was inserted into the twohybrid`bait' vector pAS2-1 and used for the two-hybrid interaction probe.
Cell culture and transfections
293 cells were grown in DMEM (Life Technologies, Karlsruhe, Germany) supplemented with 10% fetal calf serum (FCS) and penicillin/streptomycin. Ca-precipitate transfection was done according to standard methods.
Western blotting
To verify the integrity of the baits, interaction targets and the GST-fusion constructs the correct expression of the encoded proteins was controlled by Western analysis of extracts from yeast cells prepared according to Clontech's Yeast Protocols Handbook. Proteins were detected by ECL either with an anti-GAL4 DNA binding domain monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), an anti-GAL4 activation domain monoclonal antibody (Clontech) or an anti-GST monoclonal antibody (Santa Cruz Biotech). Correct expression of the¯ag-ENL,¯ag-ENLD15 and HA-hPc3 proteins was checked by western blotting of cell extracts from transiently transfected 293 cells prepared as described (Garcia-Cuellar et al., 2000) .
Two-hybrid assay
For the yeast two-hybrid screening the baits and target plasmids were cotransfected into the yeast strain PJ69-4A (James et al., 1996) according to standard protocols.
Protein production, GST-pulldown experiments and far-Western blots
All proteins used for the in vitro interaction experiments were either produced by in vitro transcription/translation with the TNT system (Promega) or by expression and puri®cation of GST fusion proteins in yeast (YEXpress system, Clontech) according to the instructions of the manufacturers. The GST pulldown assay and the far Western blot procedure have been described (Garcia-Cuellar et al., 2000) .
Co-immunoprecipitation and co-localization
Extracts from transfected 293 cells were either precipitated with a mouse monoclonal anti-¯ag antibody followed by detection with a rat monoclonal anti-HA antibody or vice versa with a rabbit polyclonal anti-HA serum and analysis with an anti-¯ag antibody. The precipitation procedure was done as described (Garcia-Cuellar et al., 2000) . For the co-localization studies 293 cells were co-transfected with the constructs pEGFP-C1-ENL and pDsRed1N1-hPc3 and the living cells were examined directly with a¯uorescence microscope.
